Effects of suryanamaskar on peak expiratory flow rate and quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD)

Aayushi Palor, D. Anandhi


Aayushi Palor, D. Anandhi – Effects of suryanamaskar on peak expiratory flow rate and quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD). Fizjoterapia Polska 2023; 23(1); 80-86

DOI: https://doi.org/10.56984/8ZG07B401

Abstract
Background. Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable, and treatable disease characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases. Surya Namaskar is an ancient yogic method to worship the sun. This specific postural and breathing protocols were developed in Indian Subcontinent in the 17th century by Saint Samarth Ramdass. Aim. To find out the effects of Suryanamaskar on peak expiratory flow rate and quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD). Methods. Experimental design, pre and post type. 14 COPD patients, aged 35–50 years, both men and women, grade I and II in GOLD classification was randomly allotted into two groups. The patients had to clear the flexibility tests – Sit and reach test and back scratch test. For the Experimental group (n = 7), Suryanamaskar, with conventional chest physiotherapy intervention, was given for 5 days per week for 6 weeks. For the control group (n = 7), conventional chest physiotherapy intervention was given for the same duration. Outcome measures: Peak expiratory flow rate (l/min), SF–36 questionnaire. Results: The study showed that the peak expiratory flow rate and SF–36 questionnaire showed non-significant result for both the groups as p > 0.05, though there was a clinically significant improvement. Conclusion: This study concluded that there is no statistically significant improvement in PEFR and QOL in COPD patients who performed Suryanamaskar along with chest physiotherapy.

Słowa kluczowe:
COPD, Peak expiratory flow rate, QOL, SF–36, Suryanamaskar

Pobierz/Download/下載/Cкачиваете Atsisiųskite straipsnį anglų kalba nemokamai

Effect of incentive spirometry on pulmonary function test in post COVID-19 pneumonia patients

Loganathan D., Malavika D., D. Anandhi, Shirly M., Pugazhendhi S., N. Nalini Jayanthi


Loganathan D., Malavika D., D. Anandhi, Shirly M., Pugazhendhi S., N. Nalini JayanthiLoganathan D., Malavika D., D. Anandhi, Shirly M., Pugazhendhi S., N. Nalini Jayanthi – Effect of incentive spirometry on pulmonary function test in post COVID-19 pneumonia patients. Fizjoterapia Polska 2022; 22(5); 122-128

DOI: https://doi.org/10.56984/8ZG20AZsV

Abstract

Background. COVID-19 caused by SARS-CoV-2 virus was assigned as a pandemic by WHO. Fever, breathlessness, cough and expectoration indicates lung involvement in the form of pneumonia and its most common complications are pulmonary fibrosis, chronic respiratory failure and reduced quality of life. Incentive spirometry is the relevant therapy to enhance the normal lung function and improve quality of life. Aim. To find the effect of incentive spirometry on pulmonary function test in post COVID-19 pneumonia patients. Methodology. An experimental study with simple random sampling (lottery method) of 24 patients in age group (18-68 years). The participants were randomly divided into 2 groups. Group A received pharmacotherapy and incentive spirometry and Group B received only pharmacotherapy. Computerized spirometry and Diffusion lung capacity for carbon monoxide (DLCO) was used as diagnostic tool to measure pre & post test values for both groups. Intervention was given for 4 weeks and after 4 weeks, to analyze the spirometry values post-test was taken for both groups. Outcome measures. Forced expiratory volume in the first second (FEV1), Forced vital capacity (FVC), FEV1/FVC &DLCO. Results. Statistical analysis shows significant improvement (p < 0.05) between pretest and post test values on Pulmonary Function Tests (PFT) in both Group A&B whereas there was increase in the improvement in intervention group than control group. Conclusion. Incentive spirometry improved the lung volume and capacities on PFT in post COVID-19 pneumonia patients and also these patients have mainly restrictive lung pattern by the use of DLCO.

Keywords:
FEV1, FVC, FEV1/FVC, DLCO, post COVID-19 pneumonia patients, incentive spirometry

Pobierz/Download/下載/Cкачиваете Atsisiųskite straipsnį anglų kalba nemokamai

Effects of Buteyko therapy on dipping of peak expiratory flow rate and quality of life in asthmatic patients among adult and elderly population

D. Anandhi, M. Tamilalagan


D. Anandhi, M. Tamilalagan – Effects of Buteyko therapy on dipping of peak expiratory flow rate and quality of life in asthmatic patients among adult and elderly population. Fizjoterapia Polska 2022; 22(5); 70-75

DOI: https://doi.org/10.56984/8ZG20AxlA

Abstract

Background. Asthma is a chronic inflammatory illness of the airways characterised by airway obstruction and bronchial hyper-responsiveness that is at least partly reversible. Serial peak expiratory flow measurements are frequently used in the clinical management of asthma to improve diagnose, estimate severity, and screen for provocative variables. When compared to mild persistent asthma, moderate to severe asthma has a lower QOL. Objective. The study’s aim is to determine the impact of Buteyko treatment on asthmatic patients’ peak expiratory flow rate (Expiratory flow rate) and quality of life. Study design. Pre and post type experimental design. Procedure. Twenty-two mild to moderate asthmatic patients, both men and women, aged 25–60 years, were randomly selected and given a peak expiratory flow metre to measure peak expiratory flow rate in the morning and evening at the same time every day. Basic chest physiotherapy was taught to all of the patients. PEFR decreased in 15 of 22 patients throughout the research period, and Buteyko treatment was administered twice daily for 6 weeks. Outcome measures. Peak Expiratory Flow Rate and Questionnaire on Shortness of Breath. Results. With Buteyko therapy, asthmatic patients’ PEFR and Shortness of Breath questionnaires improved statistically significantly (p < 0.05). Conclusion. The study found that Buteyko treatment had a substantial impact on peak expiratory flow rate lowering and asthmatic patients’ quality of life.

Keywords:
dipping, buteyko therapy, quality of life, bronchial asthma, peak expiratory flow rate, shortness of breath questionnaire

Pobierz/Download/下載/Cкачиваете Atsisiųskite straipsnį anglų kalba nemokamai